How “Liquid Biopsies” – Circulating Tumor DNA (ctDNA) Testing Are Allowing Precision Medicine in Clinic & Trials For Our Gastrointestinal Cancer Patients

Time: 1:00 pm
day: Day Two


• Feasibility and value of integrating “liquid biopsies” – circulating tumor DNA (ctDNA) testing in patients with gastrointestinal cancers
• Patient- and tumor-related factors pertaining to utility of ctDNA testing
• Clinical trials incorporating the use of liquid biopsies for patients with gastrointestinal cancers
• How liquid biopsies are allowing the promise of precision medicine to be delivered in clinic for our cancer patients